PARIS_Sanofi-Aventis SA expects to make 31 submissions for new drugs by the end of 2010, the company announced Monday.In its first such update to investors in two years, the Paris-based company, the world’s third-largest drug maker by prescription drug sales, said it has 48 drugs in late-stage development.
